BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17950382)

  • 1. Eleven years: the long and winding road.
    Ramondetta LM; Jhingran A
    Gynecol Oncol; 2007 Nov; 107(2):166-8. PubMed ID: 17950382
    [No Abstract]   [Full Text] [Related]  

  • 2. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.
    Wolfson AH; Brady MF; Rocereto T; Mannel RS; Lee YC; Futoran RJ; Cohn DE; Ioffe OB
    Gynecol Oncol; 2007 Nov; 107(2):177-85. PubMed ID: 17822748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
    Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage carcinosarcoma of the uterus: the significance of lymph node count.
    Temkin SM; Hellmann M; Lee YC; Abulafia O
    Int J Gynecol Cancer; 2007; 17(1):215-9. PubMed ID: 17291256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of adjuvant pelvic radiation "sandwiched" between ifosfamide or ifosfamide plus cisplatin in women with uterine carcinosarcoma.
    Einstein MH; Klobocista M; Hou JY; Lee S; Mutyala S; Mehta K; Reimers LL; Kuo DY; Huang GS; Goldberg GL
    Gynecol Oncol; 2012 Jan; 124(1):26-30. PubMed ID: 22055846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
    Le T
    Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Uterine carcinosarcoma].
    Serkies K; Jassem J
    Ginekol Pol; 2012 Aug; 83(8):609-12. PubMed ID: 23342885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus.
    Gerszten K; Faul C; Kounelis S; Huang Q; Kelley J; Jones MW
    Gynecol Oncol; 1998 Jan; 68(1):8-13. PubMed ID: 9454652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; van der Heijden E; Godfrey K; Naik R; Kucukmetin A; Bryant A; Das N; Lopes AD
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006812. PubMed ID: 23450572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy for high-risk cervical carcinoma].
    Yamamoto R; Sakuragi N; Okamoto K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():169-74. PubMed ID: 15535227
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
    Nemani D; Mitra N; Guo M; Lin L
    Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma.
    Galaal K; Godfrey K; Naik R; Kucukmetin A; Bryant A
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006812. PubMed ID: 21249682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.
    Makker V; Abu-Rustum NR; Alektiar KM; Aghajanian CA; Zhou Q; Iasonos A; Hensley ML
    Gynecol Oncol; 2008 Nov; 111(2):249-54. PubMed ID: 18755503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
    Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
    Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Recommended Treatment of Uterine Carcinosarcoma.
    Menczer J
    Curr Treat Options Oncol; 2015 Nov; 16(11):53. PubMed ID: 26374341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we there yet?
    Edmonson JH
    Gynecol Oncol; 2000 Nov; 79(2):145-6. PubMed ID: 11063635
    [No Abstract]   [Full Text] [Related]  

  • 18. Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis.
    Garg G; Yee C; Schwartz K; Mutch DG; Morris RT; Powell MA
    Gynecol Oncol; 2014 May; 133(2):242-9. PubMed ID: 24561247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphadenectomy for uterine cancer].
    Gouy S; Uzan C; Zafrani Y; Lhommé C; Pautier P; Duvillard P; Haie-Meder C; Morice P
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S51-12S55. PubMed ID: 19194359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.
    Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R
    Oncology; 2004; 67(1):33-9. PubMed ID: 15459493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.